NAI Senior Consultant Jill E. Sackman, D.V.M., Ph.D., and Consultant Stephen Rothenberg, J.D., discuss the challenges that oncology companies face as they introduce new products to the market in their article, Market Access—Global Challenges for Oncology Drugs.

Published May 13, 2014 in PM360, the authors focus on the growing cost sensitivity of the provider and payer marketplace, and what manufacturers of oncology drugs will need to do to succeed.